UltraScan 650 — A Leading Portable Ultrasound Bone Densitometer
Radiation‑Free Bone Density Measurement with DXA‑Equivalent Accuracy
The First and Only FDA‑Approved Ultrasound Bone Densitometer
UltraScan 650 delivers fast, accurate, radiation‑free bone density assessment using CyberLogic’s patented NTD technology
— trusted by hospitals, universities, and research labs worldwide.
Watch a Demo Download Brochure
A Breakthrough in Bone Health Assessment
UltraScan 650 provides direct BMD measurement without ionizing radiation, offering a safe and efficient alternative to DXA for screening and monitoring.
Key Advantages
- FDA‑approved for clinical bone assessment
- DXA‑equivalent accuracy BMD measurement without radiation
- Under 10‑second measurement time
- Compact & lightweight, USB-powered portable design
- Intuitive touchscreen interface
- Automated measurement workflow
- Ideal for primary care, endocrinology, and women’s health
Clinical Benefits
- High precision for longitudinal monitoring
- Reliable results across diverse patient populations
- Minimal operator training required
- Comfortable, non‑invasive procedure
- Print a report of BMD at the 1/3 radius and the T-score and z-score
UltraScan 650 uses CyberLogic’s NTD Technology to measure bone mineral density directly. The bone density measured by UltraScan 650 is highly correlated with X-ray-based (DXA) bone density measurements (r = 0.931). In contrast, the parameters measured by conventional bone sonometers (such as SOS or BUA) exhibit a poor correlation with DXA bone mineral density results (with an average correlation coefficient r of approximately 0.7). More Information
Designed for Modern Preventive Medicine
UltraScan 650 supports a wide range of clinical environments:
Clinical Applications
- Primary care & family medicine
- Endocrinology & metabolic bone clinics
- Women’s health & menopause centers
- Community screening programs for osteoporosis
- Mobile health services
Why Clinicians Choose UltraScan 650
- Zero radiation exposure for patients and staff
- Portable device goes wherever care is needed
- Results in seconds — no waiting for a lab
- Lower cost of ownership than DXA systems
- Backed by 30+ years of CyberLogic R&D
Proven in Peer‑Reviewed Studies
UltraScan 650 has been validated in multiple clinical trials demonstrating:
- Strong correlation with DXA measurements
- High reproducibility across repeated assessments
- Excellent sensitivity for low bone density detection
[Please See Quick Links below for more information]
